Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: A polymer chain conducts the protein orchestra

International Journal of Experimental Pathology

Volumn 96, Issue 4, 2015, Pages 203-231

  Gallagher, John ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Glycosaminoglycan; Heparan sulphate; Heparan sulphate heparin

Indexed keywords

ANGIOGENIC FACTOR; COLLAGEN ALPHA4V; COLLAGEN DERIVATIVE; COLLAGEN Q; COLLAGEN TYPE 1; COLLAGEN TYPE 5; COLLAGEN TYPE 9; FIBRILLIN; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; HEPARAN SULFATE; INTERLEUKIN 8; MIP1 ALPHA; MORPHOGEN; NEUROPILIN; NEUROTROPHIC FACTOR; PLEIOTROPHIN; RECEPTOR; SCATTER FACTOR; SONIC HEDGEHOG PROTEIN; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1GAMMA; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CELL ADHESION; CELL MATURATION; DIFFUSION; EXTRACELLULAR MATRIX; GLIA CELL; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; REGULATORY MECHANISM; ANIMAL; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; EXTRACELLULAR MATRIX; HEPARITIN SULFATE; HUMANS; SIGNAL TRANSDUCTION;

EID: 84939607385     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12135     Document Type: Article

References (231)

1. Ai X., Do A.T., Lozynska O., Kusche-Gullberg M., Lindahl U. & Emerson C.P. (2003) Qsulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J. Cell Biol. 162, 341-351.
2. Ai X., Kitazawa T., Do A.T., Kusche-Gullberg M., Labosky P.A. & Emerson C.P. Jr (2007) SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation. Development 134, 3327-3338.
3. Alfano I., Vora P., Mummery R., Mulloy B. & Rider C. (2007) The major determinant of the heparin binding of glial cell-line-derived neurotrophic factor is near the N-terminus and is dispensable for receptor binding. Biochem. J. 404, 131-140.
4. Allen B.L. & Rapraeger A.C. (2003) Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J. Cell Biol. 163, 637-648.
5. Allen B.L., Filla M.S. & Rapraeger A.C. (2003) Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J. Cell Biol. 155, 845-858.
6. Arrington C.B. & Yost H.J. (2009) Extra-embryonic syndecan 2 regulates organ primordia migration and fibrillogenesis throughout the zebrafish embryo. Development 136, 3143-3152.
7. Asai T., Watanabe K., Ichihara-Tanaka K. et al. (1997) Identification of heparin-binding sites in midkine and their role in neurite-promotion. Biochem. Biophys. Res. Commun. 236, 66-70.
8. Ashikari-Hada S., Habuchi H., Kariya Y., Itoh N., Reddi A.H. & Kimata K. (2004) Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J. Biol. Chem. 279, 12346-12354.
9. Ashikari-Hada S., Habuchi H., Kariya Y. & Kimata K. (2005) Heparin regulates VEGF165-dependent mitogenic activity, tube formation and its receptor phosphorylation of human endothelial cells: comparison of the effects of heparin and modified heparins. J. Biol. Chem. 280, 31508-31515.
10. Ayers K.L., Gallet A., Staccini-Lavenant L. & Thérond L.P. (2010) The long-range activity of hedgehog is regulated in the apical extracellular space by the glypican dally and the hydrolase notum. Dev. Cell 18, 605-620.
11. Baloh R., Enomoto H., Johnson E. & Milbrandt J. (2000) The GDNF family ligands and receptors - implications for neural development. Curr. Opin. Neurobiol. 10, 103-110.
12. Barkalow F.J. & Schwarzbauer J.E. (1991) Localization of the major heparin-binding site in fibronectin. J. Biol. Chem. 266, 7812-7818.
13. Barnett M.W., Fisher C.E., Perona-Wright G. & Davies J.A. (2002) Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulfate glycosaminoglycan. J. Cell Sci. 115, 4495-4503.
14. Bax D.V., Mahalingham Y., Cain S. et al. (2007) Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation. J. Cell Sci. 120, 1383-1392.
15. Beenken A. & Mohammadi M. (2009) The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discovery 8, 235-253.
16. Bespalov M.M., Sidorova Y.A., Tumova S. et al. (2011) Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J. Cell Biol. 192, 153-169.
17. Birchmeier C., Birchmeier W., Gherardi E. & Vande Woude G.F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 4, 915-925.
18. Bonnaffé D. (2011) Bioactive synthetic heparan sulfate and heparin derivatives: from long fragments mimetics to chimeras. C. R. Chim. 14, 59-73.
19. Brandan E., Maldonado M., Garrido J. & Inestrosa N.C. (1985) Anchorage of collagen-tailed acetylcholinesterase to the extracellular matrix is mediated by heparan sulfate proteoglycans. J. Cell Biol. 101, 985-992.
20. Brown A., Robinson C.J., Gallagher J.T. & Blundell T.L. (2013) Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes. Biophys. J. 104, 1720-1730.
21. Buczek-Thomas J.A., Chu C.L., Rich C.B., Stone P.J., Foster J.A. & Nugent M.A. (2002) Heparan sulfate depletion within pulmonary fibroblasts: implications for elastogenesis and repair. J. Cell. Physiol. 192, 294-303.
22. Bullock S., Fletcher J., Beddington R. & Wilson V. (1998) Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 12, 1894-1906.
23. Bulow H.E. & Hobert O. (2006) The molecular diversity of glycosaminoglycans shapes animal development. Annu. Rev. Cell Dev. Biol. 22, 375-407.
24. Busby T.F., Argraves W.S., Brew S.A., Pechik I., Gilliland G.L., Ingham K.C. (1995) Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle. J. Biol. Chem. 270, 18558-18562.
25. Cain S.A., Baldock C., Gallagher J.T. et al. (2005) Fibrillin-1 interactions with heparin. Implications for microfibril and elastic fiber assembly. J. Biol. Chem. 280, 30526-30537.
26. Cain S.A., Baldwin A.K., Mahalingham Y. et al. (2008) Heparan sulfate regulates fibrillin-1 N- and C-terminal interactions. J. Biol. Chem. 283, 27017-27027.
27. Cain S.A., McGovern A., Baldwin A., Baldock C., Kielty C.M. (2012) Fibrillin-1 mutations causing Weill-Marchesani syndrome and acromicric and geleophysic dysplasias disrupt heparan sulfate interactions. PLoS ONE 7, e48634.
28. Capila I. & Linhardt R.J. (2002) Heparin-protein interactions. Agnew. Chem. Ed. Engl. 41, 391-412.
29. Cardin A.D. & Weintraub H.J.R. (1989) Molecular modelling of protein-glycosaminoglycan interactions. Atherosclerosis 9, 21-32.
30. Carey D.J. (1996) N-syndecan: structure and function of a transmembrane heparan sulfate proteoglycan. Perspect. Dev. Neurobiol. 3, 331-346.
31. Cartaud A., Strochlic L., Guerra M. et al. (2004) MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction. J. Cell Biol. 165, 505-515.
32. Casu B. & Lindahl U. (2001) Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 57, 159-206.
33. Caterson B. (2012) Fell-Muir Lecture: Chondroitin sulphate glycosaminoglycans: fun for some and confusion for others. Int. J. Exp. Pathol. 93, 1-10.
34. Catlow K.R., Deakin J.A., Wei Z. et al. (2008) Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulphate density. J. Biol. Chem. 283, 5235-5248.
35. Chang S.C., Mulloy B., Magee A.I. & Couchman J.R. (2011) Two distinct sites in sonic Hedgehog combine for heparan sulfate interactions and cell signalling functions. J. Biol. Chem. 286, 44391-44402.
36. Chernousov M.A., Stahl R.C. & Carey D.J. (1996) Schwann cells secrete a novel collagen-like adhesive protein that binds N-syndecan. J. Biol. Chem. 271, 3844-13853.
37. Chernousov M.A., Stahl R.C. & Carey D.J. (2001) Schwann cell type V collagen inhibits axonal outgrowth and promotes Schwann cell migration via distinct adhesive activities of the collagen and noncollagen domains. J. Neurosci. 21, 6125-6135.
38. Choi Y., Chung H., Jung H., Couchman J.R. & Oh E.S. (2011) Syndecans as cell surface receptors: unique structure equates with functional diversity. Matrix Biol. 30, 93-99.
39. Chuang C.Y., Lord M.S., Melrose J. et al. (2010) Heparan sulfate-dependent signalling of fibroblast growth factor 18 by chondrocyte-derived perlecan. Biochemistry 49, 5524-5532.
40. Clore G.M., Appella E., Yamada M., Matsushima K. & Gronenborn A.M. (1990) Three-dimensional structure of interleukin 8 in solution. Biochemistry 29, 1689-1696.
41. Couchman J.R. (2010) Transmembrane signalling proteoglycans. Annu. Rev. Cell Dev. Biol. 26, 89-114.
42. Couchman J.R. & Pataki C.A. (2012) An introduction to proteoglycans and their localisation. J. Histochem. Cytochem. 60, 885-897.
43. Dai E., Liu L.Y., Wang H. et al. (2010) Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection. PLoS ONE 6, 5.
44. Davies J.A., Yates E.A. & Turnbull J.E. (2003) Structural determinants of heparan sulfate modulation of GDNF signalling. Growth Factors 21, 109-119.
45. Deakin J.D., Blaum B.S., Gallagher J.T., Uhrin D. & Lyon M. (2008) The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns. J. Biol. Chem. 284, 6311-6321.
46. Dejima K., Kanai M.I., Akiyama T., Levings D.C., Nakato H. (2011) Novel contact-dependent bone morphogenetic protein (BMP) signalling mediated by heparan sulfate proteoglycans. J. Biol. Chem. 286, 17103-17111.
47. Delacoux F., Fichard A., Gourjon C., Garrone R. & Ruggiero F. (1998) Molecular features of the collagen V heparin binding site. J. Biol. Chem. 273, 15069-15076.
48. Delacoux F., Fichard A., Cogne S., Garrone R. & Ruggiero F. (2000) Unraveling the amino acid sequence crucial for heparin binding to collagen V. J. Biol. Chem. 275, 29377-29382.
49. Delehedde M., Lyon M., Vidyasagar R., McDonnell T.J. & Fernig D. (2002) Hepatocyte growth factor/scatter factor binds to small heparin-derived oligosaccharides and stimulates proliferation of human HaCaT cells. J. Biol. Chem. 277, 12456-12462.
50. Deprez P., Inestrosa N.C. & Krejci E. (2003) Two different heparin-binding domains in the triple-helical domain of colq, the collagen tail subunit of synaptic acetylcholinesterase. J. Biol. Chem. 278, 23233-23242.
51. Dhoot G.K., Gustafsson M.K., Ai X., Sun W., Standiford D.M. & Emerson C.P. (2001) Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293, 1663-1666.
52. Dierker T., Dreier R., Migone M., Hamer S. & Grobe K. (2009a) Heparan sulfate and transglutaminase activity are required for the formation of covalently cross-linked hedgehog oligomers. J. Biol. Chem. 284, 32562-32571.
53. Dierker T., Dreier R., Petersen A., Bordych C. & Grobe K. (2009b) Heparan sulfate-modulated, metalloprotease-mediated sonic hedgehog release from producing cells. J. Biol. Chem. 284, 8013-8022.
54. DiGabriele A.D., Lax I., Chen D.I. et al. (1998) Structure of a heparin-linked biologically-active dimer of fibroblast growth factor. Nature 393, 812-817.
55. Duchesne L., Octeau V., Bearon R.N. et al. (2012) Transport of fibroblast growth factor 2 in the pericellular matrix is controlled by the spatial distribution of its binding sites in heparan sulfate. PLoS Biol. 10, e1001361.
56. Erdman R., Stahl R.C., Rothblum K., Chernousov M.A. & Carey D.J. (2002) Schwann cell adhesion to a novel heparan sulfate binding site in the N-terminal domain of α4 type V collagen is mediated by syndecan-3. J. Biol. Chem. 277, 7619-7625.
57. Esko J.D. & Lindahl U. (2001) Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169-173.
58. Faham S., Hileman R.E., Fromm J.R., Linhardt R.J. & Rees D.C. (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116-1120.
59. Fallahi A., Kroll B., Warner L.R. & Oxford R.J. (2005) Structural model of the amino propeptide of collagen XI α1 chain with similarity to the LNS domains. Protein Sci. 14, 1526-1537.
60. Farshi P., Ohlig F., Pickhinke U. et al. (2011) Dual roles of the Cardin-Weintraub motif in multimeric Sonic hedgehog. J. Biol. Chem. 286, 23608-23619.
61. Ferrara N. (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581-611.
62. Ferreras C., Rushton G., Cole G.L. et al. (2012) Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. J. Biol. Chem. 287, 36132-36146.
63. Filmus J. & Capurro M. (2014) The role of glypicans in Hedgehog signalling. Matrix Biol. 35, 248-252.
64. Forster M. & Mulloy B. (2006) Computational approaches to the identification of heparin binding sites on the surfaces of proteins. Biochem. Soc. Trans. 34, 431-434.
65. Frese M.A., Milz F., Dick M., Lamanna W.C. & Dierks T. (2009) Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain. J. Biol. Chem. 284, 28033-28044.
66. Fromm J.R., Hileman R.E., Caldwell E.E.O., Weiler J.M. & Linhardt R.J. (1995) Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch Biochem Biophys 323, 279-287.
67. Fuster M.M., Wang L., Castagnola J. et al. (2007) Genetic alteration of endothelial heparan sulfate selectively inhibits tumour angiogenesis. J. Cell Biol. 177, 539-549.
68. Gallagher J.T. (2001) Heparan sulfate: growth control with a restricted sequence menu. J. Clin. Invest. 108, 357-361.
69. Gallagher J.T., Lyon M. (2000) Heparan sulphate. Molecular structure and interactions with growth factors and morphogens. In: Proteoglycans; Structure, Biology and Molecular Interactions, pp. 27-60 (ed. R.V. Iozzo ), New York, NY - Basel: Marcel Dekker Inc.
70. Gallagher J.T. & Walker A. (1985) Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides. Biochem. J. 23, 665-674.
71. Giraldez A.J., Copley R.R. & Cohen S.M. (2002) HSPG modification by the secreted enzyme Notum shapes the Wingless morphogen gradient. Dev. Cell 2, 667-676.
72. Goetz R. & Mohammadi M. (2013) Exploring mechanisms of FGF signalling through the lens of structural biology. Nat. Rev. Mol. Cell Biol. 14, 166-180.
73. Goger B., Halden Y., Rek A. et al. (2001) Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 41, 1640-1646.
74. Goodger S.J., Robinson C.J., Murphy K.J. et al. (2008) Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. J. Biol. Chem. 283, 13001-13008.
75. Grünewald F.S., Prota A.E., Giese A. & Ballmer-Hofer K. (2010) Structure-function analysis of VEGF receptor activation and the role of co-receptors in angiogenic signalling. Biochim. Biophys. Acta 1804, 567-580.
76. Guerrini M., Agulles T., Bisio A. et al. (2002) Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1. Biochem. Biophys. Res. Commun. 292, 222-230.
77. Guimond S., Maccarana M., Olwin B.B., Lindahl U. & Rapraeger A.C. (1993) Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268, 23906-23914.
78. Habuchi H., Suzuki S., Saito T. et al. (1992) Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor. Biochem. J. 285, 805-813.
79. Handel T.M., Johnson Z., Crown S.E., Lau E.K. & Proudfoot A.E. (2005) Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu. Rev. Biochem. 74, 385-410.
80. Hartmann G., Prospero T., Brinkmann V. et al. (1998) Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr. Biol. 8, 125-134.
81. Hileman R.E., Fromm J.R., Weiler J.M. & Linhardt R.J. (1998) Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding regions. BioEssays 20, 156-167.
82. Holley R.J., Pickford C.E., Rushton G. et al. (2011) Influencing hematopoietic differentiation of mouse embryonic stem cells using soluble heparin and heparan sulfate saccharides. J. Biol. Chem. 286, 6241-6252.
83. Holmes O., Pillozzi S., Deakin J.A. et al. (2007) Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains. J. Mol. Biol. 367, 395-408.
84. Hufnagel L., Kreuger J., Cohen M.C. & Shraiman B.I. (2006) On the role of glypicans in the process of morphogen gradient formation. Dev. Biol. 300, 512-522.
85. Iwasaki W., Nagata K., Hatanaka H. et al. (1997) Solution structure of midkine, a new heparin-binding growth factor. EMBO J. 16, 6936-6946.
86. Jayson G.C., Miller G.J., Hansen S.U., Barath M., Gardiner J.M. & Avizienyte E. (2014) The development of anti-angiogenic heparan sulphate oligosaccharides. Biochem. Soc. Trans. 42, 1596-1600.
87. Kadomatsu K., Kishida S. & Tsubota S. (2013) The heparin-binding growth factor midkine: the biological activities and candidate receptors. J. Biochem. 153, 511-521.
88. Kakugawa S., Langton P.F., Zebisch M. et al. (2015) Notum deacylates Wnt proteins to suppress signalling activity. Nature 519, 187-192.
89. Kaneda N., Talukder A.H., Nishiyama H., Koizumi S. & Muramatsu T. (1996) Midkine, a heparin-binding growth/differentiation factor, exhibits nerve cell adhesion and guidance activity for neurite outgrowth in vitro. J. Biochem. 119, 1150-1156.
90. Kemp L.E., Mulloy B. & Gherardi E. (2006) Signalling by HGF/SF and Met: the role of heparin sulphate co-receptors. Biochem. Soc. Trans. 34, 414-417.
91. Kielty C.M., Baldock C., Lee D., Rock M.J., Ashworth J.L. & Shuttleworth A. (2002) Fibrillin: from microfibril assembly to biomechanical function. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 357, 207-217.
92. Kilpeläinen I., Kaksonen M., Kinnunen T. et al. (2000) Heparin-binding growth-associated molecule contains two heparin-binding β-sheet domains that are homologous to the thrombospondin type I repeat. J. Biol. Chem. 275, 13564-13570.
93. Kimbell L.M., Ohno K., Engel A.G. & Rotundo R.L. (2004) C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse. J. Biol. Chem. 279, 10997-11005.
94. Kinnunen T., Nolo R., Maccarana M., Lindahl U. & Rauvala H. (1996) Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulphate. J. Biol. Chem. 271, 2243-2248.
95. Kinnunen T., Kaksonen M., Saarinen J., Kalkkinen N., Peng H.B. & Rauvala H. (1998) Cortactin-src kinase signalling pathway is involved in N-syndecan-dependent neurite outgrowth. J. Biol. Chem. 273, 10702-10708.
96. Koda J.E., Rapraeger A. & Bernfield M. (1985) Heparan sulfate proteoglycans from mouse mammary epithelial cells. Basal extracellular proteoglycan binds specifically to native type I collagen fibrils. J. Biol. Chem. 260, 8157-8162.
97. Koopmann W. & Krangel M.S. (1997) Identification of a glycosaminoglycan-binding site in chemokine macrophage inflammatory protein-1α. J. Biol. Chem. 272, 10103-10109.
98. Kramer K.L. & Yost H.J. (2002) Ectodermal syndecan-2 mediates left-right axis formation in migrating mesoderm as a cell-nonautonomous Vg1 cofactor. Dev. Cell 2, 115-124.
99. Kreuger J. & Kjellen L. (2012) Heparan sulfate biosynthesis-regulation and variability. J. Histochem. Cytochem. 60, 898-907.
100. Kreuger J., Salmivirta M., Sturiale L., Gimenez-Gallego G. & Lindahl U. (2001) Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J. Biol. Chem. 276, 30744-30752.
101. Kreuger J., Spillmann D., Li J.P. & Lindahl U. (2006) Interactions between heparan sulphate and proteins: the concept of specificity. J. Cell Biol. 174, 323-327.
102. Krilleke D., DeErkenez A., Schubert W. et al. (2007) Molecular mapping and functional characterization of the VEGF164 heparin-binding domain. J. Biol. Chem. 282, 28045-28056.
103. Krilleke D., Ng Y.-S. & Shima D.T. (2009) The heparin-binding domainconfersdiverse functions of VEGF-A in development and disease:a structure-function study. Biochem. Soc. Trans. 37, 1201-1206.
104. Kusche-Gullberg M., Nybakken K., Perrimon N. & Lindahl U. (2012) Drosophila heparan sulfate, a novel design. J. Biol. Chem. 287, 21950-21956.
105. Laguri C., Sadir R., Rueda P. et al. (2007) The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. PLoS ONE 2, e1110.
106. Lander A. (1998) Proteoglycans: master regulators of molecular encounter? Matrix Biol. 17, 465-472.
107. Lander A.D., Nie Q. & Wan F.Y. (2002) Do morphogen gradients arise by diffusion? Dev. Cell 2, 785-796.
108. Lau E.K., Paavola C.D., Johnson Z. et al. (2004) Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J. Biol. Chem. 279, 22294-22305.
109. Ledin J., Staatz W., Li J.P. et al. (2004) Heparan sulfate structure in mice with genetically modified heparan sulfate production. J. Biol. Chem. 279, 42732-42741.
110. Li F., Nandini C.D., Hattori T. et al. (2010) Structure of pleiotrophin- and hepatocyte growth factor-binding sulfated hexasaccharide determined by biochemical and computational approaches. J. Biol. Chem. 285, 27673-27685.
111. Li F., Shi W., Capurro M. & Filmus J. (2011) Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signalling. J. Cell Biol. 192, 691-704.
112. Lietha D., Chirgadze D.Y., Mulloy B., Blundell T.L. & Gherardi E. (2001) Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. EMBO J. 20, 5543-5555.
113. Lin X. (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131, 6009-6021.
114. Lin X. & Perrimon N. (2000) Role of heparan sulfate proteoglycans in cell-cell signaling in Drosophila. Matrix Biol. 19, 303-307.
115. Lin X., Wei G., Shi Z. et al. (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev. Biol. 224, 299-311.
116. Lindahl U. & Li J.P. (2009) Interactions between heparin sulphate and proteins-design and functional implications. Int. Rev. Cell Mol. Biol. 276, 105-159.
117. Lindahl U., Kusche M., Lidholt K. & Oscarsson L.G. (1989) Biosynthesis of heparin and heparan sulphate. Ann. N.Y. Acad. Sci. 556, 36-50.
118. Lortat-Jacob H. (2009) The molecular basis and functional implications of chemokine interactions with heparan sulphate. Curr. Opin. Struct. Biol. 19, 543-548.
119. Lortat-Jacob H., Turnbull J.E. & Grimaud J.A. (1995) Molecular organization of the interferon gamma-binding domain in heparan sulphate. Biochem. J. 310, 497-505.
120. Lortat-Jacob H., Grosdidier A. & Imberty A. (2002) Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci USA. 99, 1229-1234.
121. Luo Y., Ye S., Kan M. & McKeehan W.L. (2006) Control of fibroblast growth factor (FGF7)- and FGF1-induced mitogenesis and downstream signalling by distinct heparin octasaccharide motifs. J. Biol. Chem. 281, 21052-21061.
122. Lyon M., Steward W.P., Hampson I. & Gallagher J.T. (1987) Identification of an extended N-acetylated sequence adjacent to the protein-linkage region of heparan sulphate. Biochem. J. 242, 493-498.
123. Lyon M., Deakin J. & Gallagher J.T. (1994) Liver heparan sulphate structure: a novel molecular design. J. Biol. Chem. 269, 11208-11215.
124. Lyon M., Rushton G.R., Askari J.A., Humphries M. & Gallagher J.T. (2000) Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin. J. Biol. Chem. 275, 4599-4606.
125. Lyon M., Deakin J. & Gallagher J.T. (2002) The mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor. J. Biol. Chem. 277, 1040-1046.
126. Lyon M., Deakin J.D., Lietha D., Gherardi E. & Gallagher J.T. (2004) The interactions of hepatocyte growth factor/scatter factor and Its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. J. Biol. Chem. 279, 43560-43567.
127. Maccarana M., Casu B. & Lindahl U. (1993) Minimal sequence in heparin/heparan sulphate required for binding basic fibroblast growth factor. J. Biol. Chem. 268, 23898-23905.
128. Maeda N. & Noda M. (1998) Involvement of receptor-like protein tyrosine phosphatase ζ/RPTPβ and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration. J. Cell Biol. 142, 203-216.
129. Mahalingam Y., Gallagher J.T. & Couchman J.R. (2007) Cellular adhesion responses to the heparin-binding (hepii) domain of fibronectin require heparan sulfate with specific properties. J. Biol. Chem. 282, 3221-3230.
130. Makarenkova H.P., Hoffman M.P., Beenken A. et al. (2009) Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Sci. Signal. 2, ra55.
131. Mamluk R., Gechtman Z., Kutcher M.E., Gasiunas N., Gallagher J.T. & Klagsbrun M. (2002) Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. J. Biol. Chem. 277, 24818-24825.
132. Matsuo I. & Kimura-Yoshida C. (2014) Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 369, 20130545.
133. Mayo K.H., Ilyina E., Roongta V. et al. (1995) Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding. Biochem. J. 312, 357-365.
134. McMahon A.P., Ingham P.W. & Tabin C.J. (2003) Developmental roles and clinical significance of hedgehog signaling. Curr. Top. Dev. Biol. 53, 1-114.
135. Merry C.L., Lyon M., Deakin J.A., Hopwood J.J. & Gallagher J.T. (1999) Highly sensitive sequencing of the sulphated domains of heparan sulphate. J. Biol. Chem. 274, 18455-18462.
136. Merry C.L., Bullock S.L., Swan D.C. et al. (2001) The molecular phenotype of heparan sulfate in the Hs2st-/-mutant mouse. J. Biol. Chem. 276, 35429-35434.
137. Mitsi M., Hong Z., Costello C.E. & Nugent M.A. (2006) Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry 45, 10319-10328.
138. Mobli M., Nilsson M. & Almond A. (2008) The structural plasticity of heparan sulfate NA-domains and hence their role in mediating multivalent interactions is confirmed by high-accuracy 15N-NMR relaxation studies. Glycoconj. J. 25, 401-414.
139. Mohammadi M., Olsen S.K. & Ibrahimi O.A. (2005) Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 16, 107-137.
140. Mostavi-Pour Z., Askari J.A., Whittard J.D. & Humphries M.J. (2001) Identification of a novel heparin-binding site in the alternatively-spliced IICS region of fibronectin: roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants. Matrix Biol. 20, 63-73.
141. Mulloy B. (2005) The specificity of interactions between proteins and sulfated polysaccharides. An. Acad. Bras. Ciênc. 77, 651-664.
142. Mulloy B. (2012) Structure and physiochemical characterisation of heparin. In: Heparin - A Century of Progress, pp. 77-98. (eds R. Lever, B. Mulloy & C.P. Page ), Berlin, Heidelberg: Springer Verlag.
143. Mulloy B. & Forster M.J. (2000) Conformation and dynamics of heparin and heparan sulfate. Glycobiology 10, 1147-1156.
144. Mulloy B. & Linhardt R.J. (2001) Order out of complexity - protein structures that interact with heparin. Curr. Opin. Struct. Biol. 11, 623-628.
145. Muramatsu H., Inui T., Kimura T. et al. (1994) Localization of heparin-binding, neurite outgrowth and antigenic regions in midkine molecule. Biochem. Biophys. Res. Commun. 203, 1131-1139.
146. Murphy K.J., Merry C.L.R., Lyon M., Thompson J.E., Roberts I.S. & Gallagher J.T. (2004) A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase. J. Biol. Chem. 279, 27239-27245.
147. Naimy H., Buczek-Thomas J.A., Nugent M.A., Leymarie N. & Zaia J. (2011) Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions. J. Biol. Chem. 286, 19311-19319.
148. Netelenbos T., van den Born J., Kessler F.L., Zweegman S., Huijgens P.C. & Dräger A.M. (2003) In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands. J. Leukoc. Biol. 72, 353-362.
149. Ng Y.S., Krilleke D. & Shima D.T. (2006) VEGF function in vascular pathogenesis. Exp. Cell Res. 312, 527-537.
150. Ohlig S., Farshi P., Pickhinke U. et al. (2011) Sonic hedgehog shedding results in functional activation of the solubilized protein. Dev. Cell 20, 764-774.
151. Ohlig S., Pickhinke U., Sirko S. et al. (2012) An emerging role of Sonic hedgehog shedding as a modulator of heparan sulfate interactions. J. Biol. Chem. 287, 43708-43719.
152. Ohno K., Ito M., Kawakami Y., Krejci E. & Engel A.G. (2013) Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis. Chem. Biol. Interact. 203, 335-340.
153. Ori A., Wilkinson M.C. & Fernig D.G. (2008) The heparanome and regulation of cell function: structures, functions and challenges. Front Biosci. 13, 4309-4338.
154. Parkash V., Leppänen V.-M., Virtanen H. et al. (2008) The structure of the glial cell line-derived neurotrophic factor-coreceptor complex: insights into RET signalling and heparin binding. J. Biol. Chem. 283, 35164-35172.
155. Patel V.N., Likar K.M., Zisman-Rozen S. et al. (2008) Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation. J. Biol. Chem. 283, 9308-9317.
156. Pellegrini L. (2001) Role of heparan sulfate in fibroblast growth factor signalling: a structural view. Curr. Opin. Struct. Biol. 11, 629-634.
157. Pellegrini L., Burke D.F., von Delft F., Mulloy B. & Blundell T.L. (2000) Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407, 1029-1034.
158. Proudfoot A.E., Handel T.M., Johnson Z. et al. (2003) Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl Acad. Sci. USA 100, 1885-1890.
159. Pye D., Vives R., Turnbul J.E., Hyde P. & Gallagher J.T. (1998) Heparan sulphate oligosaccharides require 6-O sulphation for promotion of basic fibroblast factor mitogenic activity. J. Biol. Chem. 273, 1183-1192.
160. Qu X., Carbe C., Tao C. et al. (2011) Lacrimal gland development and Fgf10-Fgfr2b signalling are controlled by 2-O- and 6-O-sulfated heparan sulphate. J. Biol. Chem. 286, 14435-14444.
161. Raman R., Sasisekharan V. & Sasisekharan R. (2005) Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem. Biol. 12, 267-277.
162. Ramani V.C., Yang Y., Ren Y., Nan L. & Sanderson R. (2011) Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity. J. Biol. Chem. 286, 6490-6499.
163. Rapraeger A.C., Krufka A. & Olwin B.B. (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705-1708.
164. Raulo E., Chernousov M.A., Carey D.J., Nolo R. & Rauvala H. (1994) Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J. Biol. Chem. 269, 12999-13004.
165. Rauvala H. (1989) An 18 kDa heparin-binding protein of developing brain that is distinct from fibroblast growth factors. EMBO J. 8, 2933-2941.
166. Ricard-Blum S. (2011) The collagen family. Cold Spring Harb. Perspect. Biol. 3, a004978.
167. Ricard-Blum S., Beraud M., Raynal N., Farndale R.W. & Ruggiero F. (2006) Structural requirements for heparin/heparan sulfate binding to type V collagen. J. Biol. Chem. 281, 25195-25204.
168. Rickard S.M., Mummery R.S., Mulloy B. & Rider C.C. (2003) The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFRα1. Glycobiology 13, 419-426.
169. Rider C.C. (2006) Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily. Biochem. Soc. Trans. 34, 458-461.
170. Robinson C.R. & Stringer S.E. (2006) The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114, 853-865.
171. Robinson C.J., Harmer N.J., Goodger S.J., Blundell T.L. & Gallagher J.T. (2005) Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1-FGFR2c-heparin ternary complexes. J. Biol. Chem. 280, 42274-42282.
172. 165 - binding sites within heparan sulphate encompass two highly-sulphated domains and can be liberated by K5lyase. J. Biol. Chem. 281, 1731-1740.
173. Rothblum K., Tyler W.A., Stahl R.C. & Carey D.J. (2000) Schwann cells synthesize Type V collagen that contains a novel α4 chain: molecular cloning, biochemical characterization, and high affinity heparin binding of α4 (v) collagen. J. Biol. Chem. 275, 28208-28215.
174. Rothblum K., Stahl R.C. & Carey D.J. (2004) Constitutive release of α4 type V collagen N-terminal domain by Schwann cells and binding to cell surface and extracellular matrix heparan sulfate proteoglycans. J. Biol. Chem. 279, 51282-51288.
175. Rotundo R.L., Rossi S.G., Kimbell L.M., Ruiz C. & Marrero E. (2005) Targeting acetylcholinesterase to the neuromuscular synapse. Chem. Biol. Interact. 157-158, 15-21.
176. Rubin J.B., Choi Y. & Segal R.A. (2002) Cerebellar proteoglycans regulate sonic hedgehog responses during development. Development 129, 2223-2232.
177. Rudd T.R. & Yates E.A. (2012) A highly efficient tree structure for the biosynthesis of heparan sulfate accounts for the commonly observed disaccharides and suggests a mechanism for domain synthesis. Mol. BioSyst. 8, 1499-1506.
178. Rueda P., Balabanian K., Lagane B. et al. (2008) The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. PLoS ONE 3, e2543.
179. Rueda P., Richart A., Récalde A. et al. (2012) Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions. Circulation 126, 1882-1895.
180. Ruhrberg C., Gerhardt H., Golding M. et al. (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 16, 2684-2698.
181. Sadir R., Baleux F., Grosdidier A., Imberty A. & Lortat-Jacob H. (2001) Characterization of the stromal cell-derived factor-1alpha-heparin complex. J. Biol. Chem. 276, 8288-8296.
182. Sadir R., Imberty A., Baleux F. & Lortat-Jacob H. (2004) Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J. Biol. Chem. 279, 43854-43860.
183. San Antonio J.D., Lander A.D., Karnovski M.J., Slayter H.S. (1994) Mapping the heparin-binding sites on type I collagen monomers and fibrils. J. Cell Biol. 125, 1179-1188.
184. Schlessinger J., Plotnikov A.N., Ibrahimi O.A. et al. (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743-750.
185. Schwarzbauer J.E. & DeSimone D.W. (2011) Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harb. Perspect. Biol. 3, a005041.
186. Seffouh A., Milz F., Przybylski C. et al. (2013) HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity. FASEB J. 27, 2431-2439.
187. Selleck S.B. (2001) Genetic dissection of proteoglycan function in Drosophila and C. elegans. Semin. Cell Dev. Biol. 12, 127-134.
188. Severin I.C., Gaudry J.P., Johnson Z. et al. (2010) Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans. J. Biol.Chem. 285, 17713-17724.
189. Shah M.M., Sakurai H., Sweeney D.E. et al. (2010) Hs2st mediated kidney mesenchyme induction regulates early ureteric bud branching. Dev. Biol. 339, 354-365.
190. Sharma A., Askari A.J., Humphries M.J., Jones E.Y. & Stuart D.I. (1999) Crystal structure of a heparin-and integrin-binding segment of human fibronectin. EMBO J. 18, 1468-1479.
191. Shi X. & Zaia J. (2009) Organ-specific heparan sulphate structural phenotypes. J. Biol. Chem. 284, 11806-11814.
192. Shintani Y., Takashima S., Asano Y. et al. (2006) Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J., 25, 3045-3055.
193. Shute J. (2012) Glycosaminoglycan and chemokine/growth factor interactions. In: Heparin - A Century of Progress, pp. 307-324 (eds R. Lever, B. Mulloy, C.P. Page ), Berlin, Heidelberg: Springer Verlag.
194. Skidmore M.A., Guimond S.E., Rudd T.R., Fernig D.G., Turnbull J.E. & Yates E.A. (2008) The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation. Connect. Tissue Res. 49, 140-144.
195. Smith E.M., Mitsi M. & Nugent M.A. (2009) PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation. PNAS 106, 21683-21688.
196. Spillmann D., Witt D. & Lindahl U. (1998) Defining the interleukin binding domain of heparin sulphate. J. Biol. Chem. 273, 15847-15893.
197. Staples G.O., Shi X. & Zaia J. (2010) Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains. J. Biol. Chem. 285, 18336-18343.
198. Sterner E., Masuko S., Li G. et al. (2014) Fibroblast growth factor-based signaling through synthetic heparan sulfate blocks copolymers studied using high cell density three-dimensional cell printing. J. Biol. Chem. 289, 9754-9765.
199. Stringer S.E. & Gallagher J.T. (1997) Specific binding of the chemokine platelet factor 4 to heparan sulfate. J. Biol. Chem. 272, 20508-20514.
200. Stringer S.E., Forster M.J., Mulloy B., Bishop C.R., Graham G.J. & Gallagher J.T. (2002) Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1a. Blood 100, 1543-1550.
201. Stringer S.E., Nelson M.S. & Gupta P. (2003) Identification of an MIP-1α-binding heparan sulfate oligosaccharide that supports long-term in vitro maintenance of human LTC-ICs. Blood 101, 2243-2245.
202. Sugahara K. & Kitagawa H. (2000) Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr. Opin. Struct. Biol. 10, 518-527.
203. Sugaya N., Habuchi H., Nagai N., Ashikari-Hada S. & Kimata K. (2008) 6-O-sulfation of heparan sulfate differentially regulates various FGFs-dependent signalling in culture. J. Biol. Chem. 283, 10366-10376.
204. Sweeney S.M., Guy C.A., Fields G.B. & San Antonio J.D. (1998) Defining the domains of type I collagen involved in heparin-binding and endothelial tube formation. Proc. Natl Acad. Sci. USA 90, 7275-7280.
205. Tiedemann K., Bätge B., Muller P.K. & Reinhardt D.P. (2001) Interactions of fibrillin-1 with heparin/heparan sulphate: implications for microfibrillar assembly. J. Biol. Chem. 276, 36035-36042.
206. Tu Y. & Weiss A.S. (2008) Glycosaminoglycan-mediated coacervation of tropoelastin abolishes the critical concentration, accelerates coacervate formation, and facilitates spherule fusion: implications for tropoelastin microassembly. Biomacromolecules 9, 1739-1744.
207. Turnbull J.E. & Gallagher J.T. (1990) Molecular organization of heparan sulphate from human skin fibroblasts. Biochem. J. 265, 715-724.
208. Turnbull J.E. & Gallagher J.T. (1991) Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure. Biochem. J. 273, 553-559.
209. Turnbull J.E., Fernig D.G., Ke Y., Wilkinson M.C. & Gallagher J.T. (1992) Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 267, 10337-10341.
210. Uniewicz K.A., Ori A., Xu R. et al. (2010) Differential scanning fluorimetry measurement of protein stability changes upon binding to glycosaminoglycans: a screening test for binding specificity. Anal. Chem. 82, 3796-3802.
211. Vander Kooi C.W., Jusino M.A., Perman B., Neau D.B., Bellamy H.D. & Leahy D.J. (2007) Structural basis for ligand and heparin binding to neuropilin domains. PNAS 104, 6152-6157.
212. Vaughan-Thomas A., Young R.D., Phillips A.C. & Duance V.C. (2001) Characterization of type XI collagen-glycosaminoglycan interactions. J. Biol. Chem. 276, 5303-5309.
213. Vives R.R., Sadir R., Imberty A., Rencurosi A. & Lortat-Jacob H. (2002) A kinetics and modelling study of RANTES (9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41, 14779-14789.
214. Viviano B.L., Paine-Saunders S., Gasiunas N., Gallagher J.T. & Saunders S. (2004) Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist noggin. J. Biol. Chem. 279, 5604-5611.
215. Vyas N., Goswami D., Manonmani A. et al. (2008) Nanoscale organization of hedgehog is essential for long-range signalling. Cell 133, 1214-1227.
216. Walker A. & Gallagher J.T. (1996) Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEP II). Biochem. J. 317, 871-877.
217. Walker A., Turnbull J.E. & Gallagher J.T. (1994) Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J. Biol. Chem. 269, 931-935.
218. Warner L.R., Brown R.J., Yingst S.M.C. & Oxford J.T. (2006) Isoform-specific heparan sulfate binding within the amino-terminal noncollagenous domain of collagen α1 (XI). J. Biol. Chem. 281, 39507-39516.
219. Whalen D.M., Malinauskas T., Gilbert R.J.C. & Siebold C. (2013) Structural insights into proteoglycan-shaped Hedgehog signalling. PNAS 110, 16420-16425.
220. Whitelock J. & Melrose J. (2011) Heparan sulphate proteoglycans in healthy and diseased systems. Wiley Interdiscip. Rev. Syst. Biol. Med. 3, 739-751.
221. Xu D. & Esko J.D. (2014) Demystifying heparan sulfate-protein interactions. Annu. Rev. Biochem. 83, 129-157.
222. Xu D., Fuster M.M., Lawrence R. & Esko J.D. (2011) Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J. Biol. Chem. 286, 737-745.
223. Xu R., Ori A., Rudd T.R. et al. (2012a) Diversification of the structural determinants of fibroblast growth factor-heparin interactions: implications for binding specificity. J. Biol. Chem. 287, 40061-40073.
224. Xu Y., Wang Z., Liu R., Bridges A.S., Huang X. & Liu J. (2012b) Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach. Glycobiology 22, 96-106.
225. Yan D. & Lin X. (2009) Shaping morphogen gradients by proteoglycans. Cold. Spring. Harb. Perspect. Biol. 1, a002493.
226. Yayon A., Klagsbrun M., Esko J.D., Leder P. & Ornitz D.M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.
227. Yu Y., Sweeney M.D., Saad O.M. et al. (2005) Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry. J. Biol. Chem. 280, 32200-32208.
228. Zhang X., Chen L., Bancroft D.P., Lai C.K. & Maione T.E. (1994) Crystal structure of recombinant human platelet factor 4. Biochemistry 33, 8361-8366.
229. Zhou H., Mazzulla M.J., Kaufman J.D. et al. (1998) The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site. Structure 6, 109-116.
230. Zioncheck T.F., Richardson L., Liu J. et al. (1995) Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J. Biol. Chem. 270, 16871-16878.
231. Zou P., Zou K., Muramatsu H. et al. (2003) Glycosaminoglycan structures required for strong binding to midkine, a heparin-binding growth factor. Glycobiology 13, 35-42.